Indivior (INDV)
Develops monthly injectable and sublingual medicines for opioid use disorder.
$36.20
vs last close+0.67 (+1.90%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 37 days
EPS estimate
$1.06
Revenue estimate
$329.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Aug '26Oct '26
Reported$0.32$0.41$0.51$0.72$0.82$0.96$1.15Pending
Estimate$0.32$0.22$0.26$0.38$0.65$0.64$0.87$1.06
Surprise0.0%+86.4%+96.2%+89.5%+26.2%+50.0%+32.3%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Aug '26Oct '26
Reported$299.0M$266.0M$302.0M$314.0M$358.0M$317.0M$343.0MPending
Estimate$240.1M$242.3M$255.2M$306.2M$305.6M$272.8M$306.2M$329.4M
Surprise+24.5%+9.8%+18.3%+2.5%+17.1%+16.2%+12.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.56 | — | — |
| Sep 2028 | $1.44 | — | — |
| Jun 2028 | $1.25 | — | — |
| Mar 2028 | $1.10 | — | — |
| Dec 2027 | $1.38 | — | — |
| Sep 2027 | $1.28 | — | — |
| Jun 2027 | $1.22 | — | — |
| Mar 2027 | $1.08 | — | — |
| Dec 2026 | $1.01 | — | — |
| Oct 2026 | $1.06 | — | — |
| Aug 2026 | $0.87 | $1.15 | +32.3% |
| Apr 2026 | $0.64 | $0.96 | +50.0% |
| Feb 2026 | $0.65 | $0.82 | +26.2% |
| Oct 2025 | $0.38 | $0.72 | +89.5% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Mar 2022 | |||
| Dec 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.56 | — | — | $416.1M | — | — | — |
| Sep 2028 | $1.44 | — | — | $393.8M | — | — | — |
| Jun 2028 | $1.25 | — | — | $378.3M | — | — | — |
| Mar 2028 | $1.10 | — | — | $354.0M | — | — | — |
| Dec 2027 | $1.38 | — | — | $376.1M | — | — | — |
| Sep 2027 | $1.28 | — | — | $360.2M | — | — | — |
| Jun 2027 | $1.22 | — | — | $349.2M | — | — | — |
| Mar 2027 | $1.08 | — | — | $328.0M | — | — | — |
| Dec 2026 | $1.01 | — | — | $323.6M | — | — | — |
| Oct 29, 2026 | $1.06 | — | — | $329.4M | — | — | — |
| Aug 3, 2026 | $0.87 | $1.15 | +32.3% | $306.2M | $343.0M | +12.0% | −6.6% |
| Apr 30, 2026 | $0.64 | $0.96 | +50.0% | $272.8M | $317.0M | +16.2% | +7.7% |
| Feb 26, 2026 | $0.65 | $0.82 | +26.2% | $305.6M | $358.0M | +17.1% | +0.2% |
| Oct 30, 2025 | $0.38 | $0.72 | +89.5% | $306.2M | $314.0M | +2.5% | +15.4% |
| Jul 31, 2025 | |||||||
| Apr 24, 2025 | |||||||
| Feb 20, 2025 | |||||||
| Oct 24, 2024 | |||||||
| Jul 25, 2024 | |||||||
| Apr 25, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Jul 27, 2023 | |||||||
| Apr 27, 2023 | |||||||
| Feb 16, 2023 | |||||||
| Dec 30, 2022 | |||||||
| Oct 27, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Dec 30, 2021 |